SAFETY, PHARMACODYNAMICS, PHARMACOKINETICS, AND EFFICACY OF GS-9901 IN ADULTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA, MARGINAL ZONE LYMPHOMA, CHRONIC LYMPHOCYTIC LEUKEMIA, OR SMALL LYMPHOCYTIC LYMPHOMA: